TEVA logo

TEVA Free Cash Flow

Annual FCF:

$2.05B-$269.32M(-11.61%)
December 31, 2024

Summary

  • As of today, TEVA annual free cash flow is $2.05 billion, with the most recent change of -$269.32 million (-11.61%) on December 31, 2024.
  • During the last 3 years, TEVA annual free cash flow has risen by +$165.68 million (+8.79%).
  • TEVA annual free cash flow is now -57.03% below its all-time high of $4.77 billion, reached on December 31, 2015.

Performance

TEVA Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAcash flow metrics

Quarterly FCF:

-$53.05M+$518.72M(+90.72%)
September 30, 2025

Summary

  • As of today, TEVA quarterly free cash flow is -$53.05 million, with the most recent change of +$518.72 million (+90.72%) on September 30, 2025.
  • Over the past year, TEVA quarterly free cash flow has dropped by -$937.05 million (-106.00%).
  • TEVA quarterly free cash flow is now -102.82% below its all-time high of $1.88 billion, reached on December 31, 2017.

Performance

TEVA Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAcash flow metrics

TTM FCF:

$251.19M-$937.05M(-78.86%)
September 30, 2025

Summary

  • As of today, TEVA TTM free cash flow is $251.19 million, with the most recent change of -$937.05 million (-78.86%) on September 30, 2025.
  • Over the past year, TEVA TTM free cash flow has dropped by -$2.49 billion (-90.83%).
  • TEVA TTM free cash flow is now -95.12% below its all-time high of $5.14 billion, reached on June 30, 2015.

Performance

TEVA TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

TEVA Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-11.6%-106.0%-90.8%
3Y3 Years+8.8%-107.8%-85.5%
5Y5 Years+19.9%-110.7%-89.5%

TEVA Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-11.6%+8.8%-103.6%+90.7%-90.8%at low
5Y5-Year-11.6%+19.9%-103.6%+90.7%-90.8%at low
All-TimeAll-Time-57.0%+2325.6%-102.8%+92.3%-95.1%+295.0%

TEVA Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2025
-
-$53.05M(+90.7%)
$251.19M(-78.9%)
Jun 2025
-
-$571.77M(-735.3%)
$1.19B(-43.0%)
Mar 2025
-
$90.00M(-88.5%)
$2.08B(+2.1%)
Dec 2024
$2.05B(-11.6%)
$786.00M(-11.1%)
$2.04B(-25.5%)
Sep 2024
-
$884.00M(+173.7%)
$2.74B(+32.4%)
Jun 2024
-
$323.00M(+587.2%)
$2.07B(-10.7%)
Mar 2024
-
$47.00M(-96.8%)
$2.32B(+0.4%)
Dec 2023
$2.32B(+6.7%)
$1.49B(+594.8%)
$2.31B(+19.6%)
Sep 2023
-
$213.88M(-62.5%)
$1.93B(-19.5%)
Jun 2023
-
$570.16M(+1375.8%)
$2.40B(+13.6%)
Mar 2023
-
$38.63M(-96.5%)
$2.11B(-2.8%)
Dec 2022
$2.17B(+15.4%)
$1.11B(+62.3%)
$2.17B(+25.1%)
Sep 2022
-
$683.00M(+141.3%)
$1.74B(-5.3%)
Jun 2022
-
$283.00M(+185.9%)
$1.83B(-11.0%)
Mar 2022
-
$99.00M(-85.3%)
$2.06B(+9.4%)
Dec 2021
$1.88B(-7.8%)
$673.00M(-13.7%)
$1.88B(+12.9%)
Sep 2021
-
$780.00M(+52.9%)
$1.67B(+20.4%)
Jun 2021
-
$510.00M(+745.6%)
$1.39B(-2.3%)
Mar 2021
-
-$79.00M(-117.2%)
$1.42B(-30.5%)
Dec 2020
$2.04B(+19.5%)
$458.00M(-7.8%)
$2.04B(-14.3%)
Sep 2020
-
$497.00M(-8.5%)
$2.38B(-1.1%)
Jun 2020
-
$543.00M(-0.4%)
$2.41B(+26.1%)
Mar 2020
-
$545.00M(-31.7%)
$1.91B(+11.3%)
Dec 2019
$1.71B(-51.4%)
$798.00M(+52.2%)
$1.72B(-38.6%)
Sep 2019
-
$524.36M(+1087.0%)
$2.80B(+76.5%)
Jun 2019
-
$44.17M(-87.4%)
$1.58B(-37.3%)
Mar 2019
-
$350.38M(-81.3%)
$2.53B(-28.0%)
Dec 2018
$3.52B(+32.6%)
$1.88B(+372.9%)
$3.51B(-0.2%)
Sep 2018
-
-$688.00M(-169.6%)
$3.52B(-26.7%)
Jun 2018
-
$987.98M(-25.8%)
$4.79B(+18.3%)
Mar 2018
-
$1.33B(-29.3%)
$4.05B(+52.7%)
Dec 2017
$2.65B(-38.8%)
$1.88B(+218.4%)
$2.65B(+42.5%)
Sep 2017
-
$591.61M(+141.4%)
$1.86B(-25.8%)
Jun 2017
-
$245.13M(+466.4%)
$2.51B(-17.8%)
Mar 2017
-
-$66.89M(-106.1%)
$3.05B(-29.4%)
Dec 2016
$4.34B(-9.0%)
$1.09B(-11.9%)
$4.32B(-6.0%)
Sep 2016
-
$1.24B(+57.4%)
$4.60B(+7.4%)
Jun 2016
-
$788.00M(-34.6%)
$4.28B(-10.9%)
Mar 2016
-
$1.20B(-11.9%)
$4.80B(+0.7%)
Dec 2015
$4.77B(+13.6%)
$1.37B(+48.1%)
$4.77B(-1.8%)
Sep 2015
-
$923.00M(-29.6%)
$4.86B(-5.6%)
Jun 2015
-
$1.31B(+12.1%)
$5.14B(+9.6%)
Mar 2015
-
$1.17B(-19.5%)
$4.69B(+11.8%)
Dec 2014
$4.20B(+90.4%)
$1.45B(+19.8%)
$4.20B(+30.0%)
Sep 2014
-
$1.21B(+40.8%)
$3.23B(+46.5%)
Jun 2014
-
$861.00M(+27.9%)
$2.20B(+9.4%)
Mar 2014
-
$673.00M(+39.5%)
$2.01B(-8.7%)
Dec 2013
$2.21B(-36.2%)
$482.33M(+157.0%)
$2.21B(-25.9%)
Sep 2013
-
$187.70M(-72.0%)
$2.98B(-17.3%)
Jun 2013
-
$671.40M(-22.3%)
$3.60B(-6.7%)
Mar 2013
-
$863.79M(-31.1%)
$3.86B(+11.7%)
Dec 2012
$3.46B
$1.25B(+54.7%)
$3.46B(+4.7%)
DateAnnualQuarterlyTTM
Sep 2012
-
$810.61M(-12.8%)
$3.30B(+23.8%)
Jun 2012
-
$930.01M(+101.8%)
$2.66B(-6.3%)
Mar 2012
-
$460.93M(-58.0%)
$2.84B(-7.2%)
Dec 2011
$3.06B(-10.4%)
$1.10B(+524.4%)
$3.06B(+8.1%)
Sep 2011
-
$175.72M(-84.2%)
$2.83B(-22.7%)
Jun 2011
-
$1.11B(+63.1%)
$3.67B(+8.4%)
Mar 2011
-
$680.73M(-21.6%)
$3.38B(-1.2%)
Dec 2010
$3.42B(+29.1%)
$868.43M(-13.7%)
$3.42B(+2.8%)
Sep 2010
-
$1.01B(+22.0%)
$3.33B(+7.0%)
Jun 2010
-
$825.07M(+14.5%)
$3.11B(+11.8%)
Mar 2010
-
$720.42M(-7.2%)
$2.78B(+5.2%)
Dec 2009
$2.65B(+3.5%)
$776.38M(-1.5%)
$2.65B(-7.6%)
Sep 2009
-
$788.25M(+58.5%)
$2.86B(+3.4%)
Jun 2009
-
$497.25M(-14.8%)
$2.77B(-3.9%)
Mar 2009
-
$583.81M(-41.2%)
$2.88B(-0.6%)
Dec 2008
$2.56B(+102.6%)
$992.93M(+43.2%)
$2.90B(+26.4%)
Sep 2008
-
$693.19M(+13.5%)
$2.29B(+27.8%)
Jun 2008
-
$610.69M(+1.8%)
$1.79B(+17.8%)
Mar 2008
-
$600.15M(+54.5%)
$1.52B(+20.4%)
Dec 2007
$1.26B(-23.9%)
$388.34M(+100.3%)
$1.26B(-15.8%)
Sep 2007
-
$193.92M(-42.9%)
$1.50B(-25.1%)
Jun 2007
-
$339.81M(-0.8%)
$2.00B(+12.3%)
Mar 2007
-
$342.45M(-45.2%)
$1.79B(+7.6%)
Dec 2006
$1.66B(+59.8%)
$624.82M(-10.4%)
$1.66B(+37.0%)
Sep 2006
-
$697.54M(+477.0%)
$1.21B(+49.1%)
Jun 2006
-
$120.88M(-44.2%)
$812.31M(-22.5%)
Mar 2006
-
$216.46M(+22.7%)
$1.05B(-1.3%)
Dec 2005
$1.04B(+14.0%)
$176.46M(-40.9%)
$1.06B(-9.5%)
Sep 2005
-
$298.50M(-16.4%)
$1.17B(-1.7%)
Jun 2005
-
$357.16M(+55.3%)
$1.19B(+18.3%)
Mar 2005
-
$230.03M(-20.0%)
$1.01B(+7.5%)
Dec 2004
$910.73M(+128.7%)
$287.54M(-9.8%)
$938.25M(+21.9%)
Sep 2004
-
$318.61M(+84.3%)
$769.97M(+70.6%)
Jun 2004
-
$172.85M(+8.5%)
$451.36M(+62.1%)
Mar 2004
-
$159.24M(+33.5%)
$278.50M(+133.5%)
Dec 2003
$398.26M(+136.5%)
$119.26M(+48.6%)
$119.26M(-39.8%)
Dec 2002
$168.41M(+21.1%)
-
-
Jun 2002
-
$80.25M(+6.2%)
$197.97M(+31.0%)
Mar 2002
-
$75.60M(+938.2%)
$151.09M(+8.6%)
Dec 2001
$139.08M(+159.0%)
$7.28M(-79.1%)
$139.08M(+5.5%)
Sep 2001
-
$34.84M(+4.4%)
$131.80M(+35.9%)
Jun 2001
-
$33.38M(-47.5%)
$96.96M(+52.5%)
Mar 2001
-
$63.59M
$63.59M
Dec 2000
$53.69M(-83.4%)
-
-
Dec 1999
$324.03M(+713.9%)
-
-
Dec 1998
$39.81M(-68.3%)
-
-
Dec 1997
$125.74M(+236.5%)
-
-
Dec 1996
-$92.10M(-410.4%)
-
-
Dec 1995
$29.67M(+190.3%)
-
-
Dec 1994
-$32.85M(-6437.2%)
-
-
Dec 1993
-$502.50K(+64.3%)
-
-
Dec 1992
-$1.41M(+89.3%)
-
-
Dec 1991
-$13.20M
-
-

FAQ

  • What is Teva Pharmaceutical Industries Limited annual free cash flow?
  • What is the all-time high annual free cash flow for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual free cash flow year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly free cash flow year-on-year change?
  • What is Teva Pharmaceutical Industries Limited TTM free cash flow?
  • What is the all-time high TTM free cash flow for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited TTM free cash flow year-on-year change?

What is Teva Pharmaceutical Industries Limited annual free cash flow?

The current annual free cash flow of TEVA is $2.05B

What is the all-time high annual free cash flow for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual free cash flow is $4.77B

What is Teva Pharmaceutical Industries Limited annual free cash flow year-on-year change?

Over the past year, TEVA annual free cash flow has changed by -$269.32M (-11.61%)

What is Teva Pharmaceutical Industries Limited quarterly free cash flow?

The current quarterly free cash flow of TEVA is -$53.05M

What is the all-time high quarterly free cash flow for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly free cash flow is $1.88B

What is Teva Pharmaceutical Industries Limited quarterly free cash flow year-on-year change?

Over the past year, TEVA quarterly free cash flow has changed by -$937.05M (-106.00%)

What is Teva Pharmaceutical Industries Limited TTM free cash flow?

The current TTM free cash flow of TEVA is $251.19M

What is the all-time high TTM free cash flow for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high TTM free cash flow is $5.14B

What is Teva Pharmaceutical Industries Limited TTM free cash flow year-on-year change?

Over the past year, TEVA TTM free cash flow has changed by -$2.49B (-90.83%)
On this page